The FDA asked drugmakers to participate in a pilot program designed to reduce errors caused by similarly named drugs. Three drugmakers registered for the program during the past two years, and only one submitted a complete application.
Drugmakers shun FDA pilot program on drug names
SmartBrief Job Listings for Health Care
|Sr. Business Systems Analyst||
|Chief Operating Officer||
Presence Health Partners
|Des Plaines, IL|
|Leadership Recruiting Manager||
|Sr. Reimbursement Analyst||
Olympus America Inc.
|Sr. Report Developer Medical Claims||
Geisinger Health System